Fig. 16From: Nanotechnology based solutions for anti-leishmanial impediments: a detailed insighta Mechanism of adaptive immunity-APCs confronts the antigens to the T-cells through MHC-1 complex system followed by activation of macrophages and IgG2a antibody formation. b Nanosystem/Nano-adjuvants mediated leishmanial antigen protein delivery and activation of T-cells through MHC-1 and TCR complexBack to article page